Abram Hoffer (b. 1917) is a controversial Canadian psychiatrist known for his early development of biochemically based therapies including The Use of Nutrition and vitamins in The treatment of schizophrenia, as well as other diseases. This broad approach, referred to as orthomolecular medicine, involves the strategic use of megavitamins. BackgroundHoffer earned a Bachelor of science in Agriculture ( Great Distinction ) from a US Land-grant University in 1938 , followed by a masters Degree in Agriculture. Later, he obtained a Ph.D. in biochemistry from the University of Minnesota in 1944 with research into vitamin content in cereals. Driven by a growing fascination with how nutrition affects humans, Hoffer went on to medical school, earning his MD from a US Medical School in 1949 and finishing his psychiatric residency in 1954.[1]
From 1955 to 1967, Hoffer served as a faculty member at a US University's College of Medicine. During that same period, he held the role of Director of Psychiatric research for a US State Department of Public health in a US city from 1950 - 67.[1] While working there, he observed that about half of the patients in the mental hospital were diagnosed with schizophrenia. Noticing that both the facility conditions and the standard patient care were quite lacking, he began searching for better ways to support those struggling with mental illness.[2] He leaned into biochemistry and human physiology as a way to advance psychiatric research, often questioning the reliance on psychosomatic psychoanalysis and the lack of precise measurements in traditional psychiatric methods.
By the middle of the 1960s, the psychiatric mainstream was shifting its focus heavily toward neuroleptic drugs. As a result, they began to sideline Hoffer’s orthomolecular theories and refused to publish any research that supported orthomolecular medicine.[3] Consequently, in 1967, Hoffer stepped down from his academic and directorial roles to start a private practice in Saskatoon. It was during this time that he founded The Journal of Schizophrenia to ensure research regarding orthomolecular psychiatry had a place to be published. Following a few title changes over the years, this publication eventually became the Journal of Orthomolecular medicine in 1986.[3] In 1976, Hoffer moved to Victoria, British Columbia, where he maintained his private practice until retiring in 2005. Even now, Hoffer still offers nutritional consultations and serves as the editor of the Journal of Orthomolecular medicine.[2]
ResearchThrough research Working with Humphry Osmond, MD and their scientific teams , Hoffer and Osmond developed The oxidized adrenalin, the Hoffer-Osmond Diagnostic test, niacin therapy for schizophrenia, and various tests for hallucinogenic indole metabolites.[4]
While trying to find effective treatments for alcoholism, Hoffer and Osmond did Studies with LSD. Based on the theory that many alcoholics need to "hit bottom" before they are ready to quit, Hoffer and Osmond attempted to use LSD to essentially simulate the experience of delirium tremens. Hoffer reported a 50% success rate among 2,000 individuals, though he candidly noted that it might have been the profound psychedelic experience itself, rather than the simulation of withdrawal, that truly motivated them to stop drinking.[5]
Interestingly, while performing his psychiatric research involving niacin, Hoffer stumbled upon the first successful treatment for high cholesterol.[6] To this day, niacin remains one of the most proven cholesterol treatments for actually extending life, offering significant benefits to HDL, Lp(a), and triglycerides while helping to lower LDL in several major types of hyperlipidemia.[7] However, it is worth noting that certain time-release versions—especially some older formulations used before 1994 at doses exceeding 2 grams per day—can carry potentially serious side effects.[8][9]
After noticing specific biochemical patterns and some truly unexpected cancer recoveries among his psychiatric patients, Hoffer spent several years investigating how vitamins—specifically the B vitamins and ascorbate—might fight cancer. His work involved applying nutrient-based protocols to hundreds of cancer patients, with many reporting successful outcomes.[10] He even teamed up with Linus Pauling to explore various facets of orthomolecular medicine, with a particular focus on the anti-cancer properties of vitamin C.
The Controversy Even now, Hoffer's approaches to treating schizophrenia and his broader theories on orthomolecular medicine remain subjects of debate, as they haven't quite gained widespread traction within the mainstream medical establishment as of 2006.[11] For instance, a July 1973 report from an American Psychiatric Association Task Force regarding the use of niacin for schizophrenia pointed out methodological issues in Hoffer’s early research and noted that other studies failed to demonstrate a clear advantage for this type of therapy.[12] Naturally, Hoffer and Osmond issued a detailed rebuttal to that report, arguing that it was filled with inaccuracies, misrepresentations, and underlying biases.[13] Despite this, niacin, B6, and ascorbates aren't typically part of the standard toolkit for treating schizophrenia in conventional medicine.[14] Furthermore, some subsequent studies that didn't follow Hoffer's specific original protocols also failed to show that megavitamin therapy provided any real benefit for schizophrenia.[15]
Looking back from 2005, orthomolecular psychiatry still lacks sufficient testing and independent validation from major conventional authorities. As one might observe, "Controlled studies utilizing the orthomolecular method have been rare. The ones that did occur focused on chronic schizophrenia or groups that included bipolar and schizoaffective patients—diagnostic categories that aren't currently viewed as primary candidates for the orthomolecular approach. On top of that, some negative findings regarding high-dose niacin were observed in patients who weren't even receiving guidance on maintaining a healthy diet..."[16]
Back in the 1950s, Hoffer actually predicted that his treatments would face this kind of pushback, suggesting it might take at least forty years for his methods to reach mainstream acceptance. During an interview in 2006, he mentioned that while he found modern mainstream psychiatric care to be "terrible," he felt his own theories were finally beginning to gain some ground. He remarked, “[W]e’re at a transition point. If I live another four or five years, I’ll see it.”[2]
References1. ^ a b Hoffer, Abram. Curriculum Vitae. Health WorldOnline.
2. ^ a b c Rob Wipond. "An interview with Dr. Abram Hoffer", Focus, August 2006.
3. ^ a b Hoffer, Abram. Journal of Orthomolecular Medicine History.
4. ^ Eisner, Bruce (February 11 2004). Humphrey Osmond Inventor of the Word "Psychedelic" Dies.
5. ^ Hoffer, Abram (1970). Treatment of Alcoholism with Psychedelic Therapy.
6. ^ Altschul R; Hoffer A; Stephen JD. (1955). "Influence of Nicotinic Acid on Serum Cholesterol in Man.". Arch Biochem Biophys 54: 558–559.
7. ^ The Coronary Drug Project Research Group. (1975). "Clofibrate and niacin in coronary heart disease.". J Amer Med Assoc.: 231:360-381..
8. ^ Parsons, William (2003). Cholesterol Control Without Diet, Revised Edition, 181-211..
9. ^ Lifespan's A - Z Health Information Library - Cholesterol (2006).
10. ^ Hoffer's Home Page - Orthomolecular Treatment of Cancer. (December 26, 1999.).
11. ^ Bartlett, Stephen (July 12 2000). Orthomolecular Therapy.
12. ^ Lipton M and others (1973). "Task Force Report on Megavitamin and Orthomolecular Therapy in Psychiatry". American Psychiatric Association.
13. ^ Hoffer A., Osmond H. (August 1976). "Megavitamin Therapy in reply to The American Psychiatric Association Task Force Report on Megavitamin and Orthomolecular Therapy in Psychiatry" (PDF). American Schizophrenia Foundation.
14. ^ Complementary Schizophrenia Treatments (2004).
15. ^ Vaughan K.; McConaghy N. (1999). "Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial". Australian and New Zealand Journal of Psychiatry 33 (1): 84.
16. ^ (2005) "Treating Acute Schizophrenia Using High-Dose Niacinamide Combined with Ascorbate, Pyridoxine, and Centrum Forte versus Centrum Forte alone as an adjunct to Risperidone and dietary guidance (2005-2009 clinical trial)." Beersheva Mental Health Center.
BibliographyThis brief selection highlights just a few of Hoffer's works, much of which he wrote alongside Humphry Osmond. It’s worth noting that this doesn't even scratch the surface of his massive legacy, which includes more than 35 books [2] and a staggering collection of over 500 scientific papers [1] produced throughout his extensive career.
* Hoffer A (1960). Chemical Basis of Clinical Psychiatry. Thomas, Springfield, IL..
* Hoffer A (1962). Niacin therapy in psychiatry (American lecture series). Thomas.
* Hoffer A (1992 (1966, 1978)). How to Live With Schizophrenia, 2nd ed., revised, Citadel Press. ISBN 0-8065-1382-9.
* Hoffer A (1966). New Hope for Alcoholics. University Books.
* Hoffer A (1967). The Hallucinogens. Academic Press. ISBN 0-12-351850-4.
* Hoffer A; Osmond H; Kelm H (1975). Hoffer-Osmond Diagnostic Test. Behavior Science Press, Tuscaloosa, AL..
* Hoffer A; Pauling L (2004). Healing Cancer: Complementary Vitamin & Drug Treatments. CCNM Press. ISBN 1-897025-11-4.
* Hoffer A (2005). Adventures in psychiatry, the scientific memoirs of dr. Abram Hoffer. KOS Publishing Inc.. ISBN 0-9731945-6-1.
External links* Abram Hoffer - Biography - HealthWorld Online
* Hoffer's Home Page - Orthomolecular Treatment of Cancer
* Vitamins and Minerals Help Fight Off Diseases of The Mind and The Body - Interview with Abram Hoffer, M.D., Ph.D.
* Abram Hoffer MD, PhD Interviewed by Peter Barry Chowka On Orthomolecular Medicine
Retrieved from "
http://en.wikipedia.org/wiki/Abram_Hoffer"